Quality Matters

FEBRUARY 9, 2023

Africa’s growing vaccine capacity Manufacturing products locally for more equitable pandemic responses Every year, vaccines prevent nearly 5 million deaths around the globe. Yet, Africa produces less than 1 percent of the vaccines it needs to protect patients and communities across the continent.

Vaccines 52

Vaccines Immunity Immunization Labelling 52

Pharmaceutical Technology

SEPTEMBER 16, 2022

And despite the recent pandemic that forced the industry to develop and deliver treatments and vaccines all over the world, the issue of reducing emissions has remained high on industry leaders’ agendas. Download the white paper to learn more. [1] Industry awareness of the issues. Linda Schwär, VP Marketing, Berlinger & Co.

Vaccines 52

Vaccines Labelling 52

Pharmaceutical Technology

MARCH 21, 2023

A few weeks later, the EC extended the approval label of AstraZeneca’s Forxiga (dapagliflozin) to include the treatment of symptomatic hearth failure. The vaccine ACI-24.060 elicited an anti-Abeta antibody response in the first patient cohort after six weeks, as per the results.

Packaging 59

Packaging Vaccines Labelling Communication 59

Pharmaceutical Technology

JANUARY 5, 2023

The swift development of COVID-19 vaccines was an unprecedented scientific and collaborative achievement by government, regulators, research institutions, and the pharmaceutical industry. The pharmaceutical industry has long been labelled as a recession-proof—stable demand for medicines and new treatment options acts as a protective barrier.

Drug Pricing 69

Drug Pricing Vaccines Labelling Communication 69